These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 12163988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder.
    Schulze TG, Müller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, Windemuth C, Neidt H, Grässle M, Papassotiropoulos A, Heun R, Nöthen MM, Maier W, Lesch KP, Rietschel M.
    Am J Med Genet; 2000 Dec 04; 96(6):801-3. PubMed ID: 11121185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic pathway of major depressive disorder in shortening telomeric length.
    Lung FW, Chen NC, Shu BC.
    Psychiatr Genet; 2007 Jun 04; 17(3):195-9. PubMed ID: 17417064
    [Abstract] [Full Text] [Related]

  • 9. [Special aspects of antidepressive therapy].
    Nervenarzt; 1994 Mar 04; 65(3 Suppl [speziell]):1-8. PubMed ID: 9218059
    [No Abstract] [Full Text] [Related]

  • 10. Moclobemide and the reversible inhibitors of monoamine oxidase antidepressants.
    Priest RG.
    Acta Psychiatr Scand Suppl; 1990 Mar 04; 360():39-41. PubMed ID: 2248065
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Tolerance to monoamine oxidase inhibitors. A case report of tolerance of nialamide and moclobemide].
    Reine G, Llorca PM, Bougerol T.
    Encephale; 1993 Mar 04; 19(6):663. PubMed ID: 12404787
    [No Abstract] [Full Text] [Related]

  • 16. Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
    Steur EN, Ballering LA.
    J Neurol Neurosurg Psychiatry; 1997 Oct 04; 63(4):547. PubMed ID: 9343144
    [No Abstract] [Full Text] [Related]

  • 17. Thyroid functioning during treatment for depression.
    Kusalic M, Engelsmann F, Bradwejn J.
    J Psychiatry Neurosci; 1993 Nov 04; 18(5):260-3. PubMed ID: 8297924
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic value of pharmaco-EEG in depression treated with moclobemide].
    Wiśniewski G, Jakitowicz J, Nowicki Z, Pankiewicz P.
    Psychiatr Pol; 2002 Nov 04; 36(6 Suppl):93-8. PubMed ID: 12647427
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide.
    Gram LF, Isacsson G, Bergman U.
    Lancet; 1994 Mar 12; 343(8898):679-80. PubMed ID: 7906848
    [No Abstract] [Full Text] [Related]

  • 20. MAOA gene polymorphisms and response to mirtazapine in major depression.
    Tzeng DS, Chien CC, Lung FW, Yang CY.
    Hum Psychopharmacol; 2009 Jun 12; 24(4):293-300. PubMed ID: 19382113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.